You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Oral Presentations
Abstract Session: Molecules – small and smart
OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Powers J, Bekker P, Dairaghi D, et al
OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders
Annals of the Rheumatic Diseases 2013;71:124.